BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2022 5:55:20 AM | Browse: 242 | Download: 465
 |
Received |
|
2021-09-06 12:27 |
|
Peer-Review Started |
|
2021-09-06 12:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-12-01 09:48 |
|
Revised |
|
2021-12-07 15:07 |
|
Second Decision |
|
2021-12-29 03:10 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-31 22:10 |
|
Articles in Press |
|
2021-12-31 22:10 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-01-07 08:59 |
|
Publish the Manuscript Online |
|
2022-02-11 05:55 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Peng-Bo Deng, Juan Jiang, Cheng-Ping Hu, Li-Ming Cao and Min Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Building Project for Major Diseases (Lung Cancer) |
|
| National Key R&D Program of China |
2016YFC1303300 |
| Xiangya Clinical Big Data Project of Central South University (Clinical big data project of lung cancer) |
|
|
| Corresponding Author |
Min Li, MD, PhD, Chief Doctor, Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Diseases, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha 410008, Hunan Province, China. limin2050@csu.edu.cn |
| Key Words |
Cytokine release syndrome; Non-small cell lung cancer; Immune checkpoint inhibitors; Nivolumab; Tumor necrosis factor α; Interleukin-1β; Interleukin-6; Case report |
| Core Tip |
Cytokine release syndrome (CRS) is defined as systemic inflammation that usually occurs after chimeric antigen receptor T-cell therapy is administered. But the case we report suggests CRS can develop in treatment-naïve lung cancer patient. Patients with tumor-related CRS may be at risk of CRS recurrence, aggravation, and onset of immune checkpoint inhibitor (ICI)-related adverse events when ICIs are administered. Therefore, it is necessary to carefully evaluate whether the patient has CRS prior to the initiation of ICI treatment. |
| Publish Date |
2022-02-11 05:55 |
| Citation |
Deng PB, Jiang J, Hu CP, Cao LM, Li M. Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report. World J Clin Cases 2022; 10(5): 1580-1585 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i5/1580.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i5.1580 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
